Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Gade

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Inflammatory Bowel Diseases|July 2, 2026
Higher body mass index is associated with lower drug concentrations in patients with inflammatory bowel disease treated with ustekinumab but not vedolizumabJoyce Lee, Rachel Porth, Alessandra Saraga, et al.
Journal of Clinical Medicine|January 28, 2026
Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel DiseaseAlessandra Saraga, Tina Deyhim, Ajay Gade, et al.
Digestive Diseases and Sciences|September 22, 2025
Sexual Health and STI Counseling Is Critical but Often Overlooked in IBDAlexander Goldowsky, Andrew Eidelberg, Grace Geeganage, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|September 22, 2025
May Measurement Month 2022: an analysis of blood pressure screening results from IndiaAnuj Maheshwari, Narsingh Verma, Ajoy Tewari, et al.
Annals of Gastroenterology|May 21, 2026
Postpartum nonsteroidal anti-inflammatory drug exposure does not increase risk for flare in patients with inflammatory bowel diseaseLoren G Rabinowitz, Tina Deyhim, Joyce Lee, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Inflammatory Bowel Diseases|July 2, 2026
Higher body mass index is associated with lower drug concentrations in patients with inflammatory bowel disease treated with ustekinumab but not vedolizumabJoyce Lee, Rachel Porth, Alessandra Saraga, et al.
Journal of Clinical Medicine|January 28, 2026
Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel DiseaseAlessandra Saraga, Tina Deyhim, Ajay Gade, et al.
Digestive Diseases and Sciences|September 22, 2025
Sexual Health and STI Counseling Is Critical but Often Overlooked in IBDAlexander Goldowsky, Andrew Eidelberg, Grace Geeganage, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|September 22, 2025
May Measurement Month 2022: an analysis of blood pressure screening results from IndiaAnuj Maheshwari, Narsingh Verma, Ajoy Tewari, et al.
Annals of Gastroenterology|May 21, 2026
Postpartum nonsteroidal anti-inflammatory drug exposure does not increase risk for flare in patients with inflammatory bowel diseaseLoren G Rabinowitz, Tina Deyhim, Joyce Lee, et al.
Pageof 2